companydata.dkNORDIC BIOTECH PRIVATE INVESTORS ApS: Financial statements 2013
CVR: 26284384
NORDIC BIOTECH PRIVATE INVESTORS ApS (CVR 26284384) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK -90,481 and a net result of DKK 7,177,105 compared with DKK 15,355,683 the year before. Equity amounted to DKK 27,200,857. The solvency ratio was 100%.
- Gross Profit
- -90,481 kr.
- Profit/Loss
- 7,177,105 kr.
- Equity
- 27,200,857 kr.
- Total Assets
- 27,210,781 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | -90 t. | 7.2 mio. | 27.2 mio. | - |
| 2012 | - | - | 15.4 mio. | 20 mio. | - |
Find more companies like NORDIC BIOTECH PRIVATE INVESTORS ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2013
NORDIC BIOTECH PRIVATE INVESTORS ApS has published its annual report for 2012. The net result was DKK 15,355,683.
About NORDIC BIOTECH PRIVATE INVESTORS ApS
NORDIC BIOTECH PRIVATE INVESTORS ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2001. The company was registered under the industry Ikke-finansielle holdingselskaber. The management consists of Jakob Mosegaard Larsen. The company's owners include Thue Walter Schwartz, Peter Moldt and Dorte Kloppenborg Skrumsager. In 2025, the company reported a gross profit of DKK -432,293 and a net result of DKK -571,396 compared with DKK 2,080,087 the year before. Equity amounted to DKK 2,975,449.